JP2018536684A5 - - Google Patents

Download PDF

Info

Publication number
JP2018536684A5
JP2018536684A5 JP2018529982A JP2018529982A JP2018536684A5 JP 2018536684 A5 JP2018536684 A5 JP 2018536684A5 JP 2018529982 A JP2018529982 A JP 2018529982A JP 2018529982 A JP2018529982 A JP 2018529982A JP 2018536684 A5 JP2018536684 A5 JP 2018536684A5
Authority
JP
Japan
Prior art keywords
oxo
thia
dihydro
carboxamide
triazaacenaphthylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018529982A
Other languages
English (en)
Japanese (ja)
Other versions
JP7110097B2 (ja
JP2018536684A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/065964 external-priority patent/WO2017100668A1/en
Publication of JP2018536684A publication Critical patent/JP2018536684A/ja
Publication of JP2018536684A5 publication Critical patent/JP2018536684A5/ja
Priority to JP2022115945A priority Critical patent/JP7471348B2/ja
Application granted granted Critical
Publication of JP7110097B2 publication Critical patent/JP7110097B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018529982A 2015-12-10 2016-12-09 ブルトン型チロシンキナーゼの阻害剤及びその使用方法 Active JP7110097B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022115945A JP7471348B2 (ja) 2015-12-10 2022-07-20 ブルトン型チロシンキナーゼの阻害剤及びその使用方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562265780P 2015-12-10 2015-12-10
US62/265,780 2015-12-10
PCT/US2016/065964 WO2017100668A1 (en) 2015-12-10 2016-12-09 Inhibitors of bruton's tyrosine kinase and methods of their use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022115945A Division JP7471348B2 (ja) 2015-12-10 2022-07-20 ブルトン型チロシンキナーゼの阻害剤及びその使用方法

Publications (3)

Publication Number Publication Date
JP2018536684A JP2018536684A (ja) 2018-12-13
JP2018536684A5 true JP2018536684A5 (enExample) 2020-03-12
JP7110097B2 JP7110097B2 (ja) 2022-08-01

Family

ID=57681785

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018529982A Active JP7110097B2 (ja) 2015-12-10 2016-12-09 ブルトン型チロシンキナーゼの阻害剤及びその使用方法
JP2022115945A Active JP7471348B2 (ja) 2015-12-10 2022-07-20 ブルトン型チロシンキナーゼの阻害剤及びその使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022115945A Active JP7471348B2 (ja) 2015-12-10 2022-07-20 ブルトン型チロシンキナーゼの阻害剤及びその使用方法

Country Status (16)

Country Link
US (3) US10689396B2 (enExample)
EP (1) EP3386992B1 (enExample)
JP (2) JP7110097B2 (enExample)
KR (1) KR20180094514A (enExample)
CN (2) CN113105475B (enExample)
AR (1) AR107041A1 (enExample)
AU (1) AU2016366546B2 (enExample)
BR (1) BR112018011525B1 (enExample)
CA (1) CA3007993C (enExample)
EA (1) EA038031B1 (enExample)
IL (1) IL259862B (enExample)
JO (1) JO3793B1 (enExample)
MX (1) MX386700B (enExample)
TW (1) TWI739779B (enExample)
UY (1) UY37016A (enExample)
WO (1) WO2017100668A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3003987B2 (ja) 1996-08-20 2000-01-31 篠▲崎▼ 晴彦 合成樹脂管内に施設されるケーブルの支持装置及びそのケーブル支持具を取付ける方法
JO3793B1 (ar) 2015-12-10 2021-01-31 Janssen Pharmaceutica Nv مثبطات تيروزين كاينيز بروتون وأساليب استخدامها
JO3794B1 (ar) 2015-12-10 2021-01-31 Janssen Pharmaceutica Nv المركبات متعددة الحلقات كمثبطات لتيروزين كيناز بروتون
EP3596087A1 (en) * 2017-03-15 2020-01-22 Janssen Sciences Ireland Unlimited Company Methods of selective aryl- and heteroaryl-nitrogen bond formation
CN110028525A (zh) * 2018-04-13 2019-07-19 太仓运通新材料科技有限公司 一种2-氟磷酰基乙酸三乙酯的合成方法
IL278291B2 (en) 2018-05-17 2023-10-01 Forma Therapeutics Inc Fused bicyclic compounds useful as ubiquitin-specific peptidase 30 inhibitors
LT3860989T (lt) * 2018-10-05 2023-06-12 Forma Therapeutics, Inc. Sulieti pirolinai, kurie veikia kaip ubikvitinui specifinės proteazės 30 (ups30) inhibitoriai
TW202039512A (zh) 2018-12-06 2020-11-01 日商第一三共股份有限公司 環烷-1,3-二胺化合物
WO2021043200A1 (zh) * 2019-09-04 2021-03-11 正大天晴药业集团股份有限公司 一种喹唑啉衍生物的制备方法及其结晶
CN111635368B (zh) * 2020-06-12 2021-06-29 东莞市东阳光仿制药研发有限公司 一种胺化合物的制备方法
CN114478346A (zh) * 2021-12-31 2022-05-13 和鼎(南京)医药技术有限公司 一种制备乌帕替尼中间体的方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3112415A1 (de) 1981-03-28 1982-10-07 Dynamit Nobel Ag, 5210 Troisdorf Verfahren zur chlorierung von cyclischen amiden und cyclischen vinylogen amiden
US5430150A (en) 1992-12-16 1995-07-04 American Cyanamid Company Retroviral protease inhibitors
US5300478A (en) 1993-01-28 1994-04-05 Zeneca Limited Substituted fused pyrazolo compounds
EP1789055A4 (en) 2004-09-15 2009-11-11 Janssen Pharmaceutica Nv INHIBITORS OF THIAZOLOPYRIDINE KINASE
US7579356B2 (en) 2005-05-04 2009-08-25 Janssen Pharmaceutica Nv Thia-tetraazaacenaphthylene kinase inhibitors
WO2007019191A2 (en) 2005-08-08 2007-02-15 Janssen Pharmaceutica, N.V. Thiazolopyrimidine kinase inhibitors
WO2007092879A2 (en) * 2006-02-08 2007-08-16 Janssen Pharmaceutica, N.V. Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitors
DK2529622T3 (en) 2006-09-22 2018-05-07 Pharmacyclics Llc INHIBITORS OF BRUTON-TYROSINKINASE
US8598174B2 (en) * 2008-11-12 2013-12-03 Genetech, Inc. Pyridazinones, method of making, and method of use thereof
WO2011133609A2 (en) 2010-04-19 2011-10-27 The Translational Genomics Research Institute Methods and kits to predict therapeutic outcome of btk inhibitors
FR2978441A1 (fr) 2011-07-25 2013-02-01 Diverchim Nouveaux analogues de ceramides, leurs procedes de preparation et leurs applications dans les compositions pharmaceutiques et cosmetiques
AU2014230935A1 (en) 2013-03-15 2015-09-03 Janssen Pharmaceutica Nv Processes and intermediates for preparing a medicament
ES2678021T3 (es) * 2013-12-11 2018-08-08 Biogen Ma Inc. Compuestos de biarilo útiles para el tratamiento de enfermedades humanas en oncología, neurología e inmunología
JO3793B1 (ar) 2015-12-10 2021-01-31 Janssen Pharmaceutica Nv مثبطات تيروزين كاينيز بروتون وأساليب استخدامها
JO3794B1 (ar) 2015-12-10 2021-01-31 Janssen Pharmaceutica Nv المركبات متعددة الحلقات كمثبطات لتيروزين كيناز بروتون
WO2018103058A1 (en) 2016-12-09 2018-06-14 Janssen Pharmaceutica Nv Inhibitors of bruton's tyrosine kinase and methods of their use
WO2018103060A1 (en) 2016-12-09 2018-06-14 Janssen Pharmaceutica Nv Inhibitors of bruton's tyrosine kinase and methods of their use

Similar Documents

Publication Publication Date Title
JP2018536684A5 (enExample)
US8278295B2 (en) Amino-heterocyclic compounds
JP2023071767A (ja) Brm標的化化合物および関連使用方法
JP6655052B2 (ja) ビヘテロアリール化合物及びその使用
EP3237418B1 (en) Triazolopyrimidine compounds and uses thereof
NL2000323C2 (nl) Pyrimidine-derivaten.
RU2484091C2 (ru) Производные изоксазоло-пиридина
JP2017505794A5 (enExample)
JP2009513575A5 (enExample)
JP2019512482A5 (enExample)
US20160060262A1 (en) Substituted 6,6-Fused Nitrogenous Heterocyclic Compounds and Uses Thereof
JP2018536686A5 (enExample)
US12344603B2 (en) Pyrido-pyrimidinone and pteridinone compounds and methods of use
JP2017524007A5 (enExample)
HRP20130106T1 (hr) Imidazotriazini i imidazopirimidini kao inhibitori kinaze
JP2019523233A5 (enExample)
JP2012501312A5 (enExample)
IL259863A (en) Polycyclic compounds as inhibitors of bruton's tyrosine kinase
JP2016523911A5 (enExample)
EP2516436A1 (en) Imidazopyridine derivatives as jak inhibitors
JP2016523976A5 (enExample)
JPWO2021076602A5 (enExample)
JP2017519023A5 (enExample)
RU2018117503A (ru) ЗАМЕЩЕННЫЕ ИНДАЗОЛЬНЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ RORγТ И ИХ ПРИМЕНЕНИЕ
JP2014501772A5 (enExample)